By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1elBX3q Mallinckrodt to Buy California's Questcor for $5.6 Billion The cash and stock transaction is expected to expand Mallinckrodt’s offerings of specialty pharmaceuticals, namely Questcor’s primary drug Acthar, which is used to manage autoimmune and inflammatory conditions. April 7, 2014 at 4:00AM http://nyti.ms/1elBX3q http://nyti.ms/1hTmaNT The New York Times Acthar (Drug), Autoimmune Diseases, Boards of Directors, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures, Stocks and Bonds
No comments:
Post a Comment
thank you